Literature DB >> 7680386

T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development.

M H Gatei1, M F Good, R C Daniel, M F Lavin.   

Abstract

Bovine leukemia virus (BLV) is a retrovirus that infects cattle and sheep and may provide a model for studying human leukemia. Cell-mediated immune mechanisms may play a major role in protection against BLV infection. We describe here for the first time the identification of proliferative (CD4) and cytotoxic T-lymphocyte (CD8) epitopes of the gp51 envelope (env) protein of BLV. This protein and a recombinant form expressed by a vaccinia virus construct have been shown to be potential vaccine candidates. A complete series of overlapping peptides, 20 amino acids in length, was prepared to identify epitopes from gp51. These peptides were tested for the ability to elicit peripheral blood lymphocyte proliferation and cytotoxic T-lymphocyte responses in infected and uninfected cattle and sheep. Peptides 51-70 and 61-80 produced a proliferative response in lymphocytes from only uninfected animals (both sheep and cattle), and this was shown by T-cell subset deletion to be a CD4-mediated response. Seven BLV-infected sheep did not show a response to either peptide. Cytotoxic T-lymphocyte activity, however, was associated only with peptides 121-140 and 131-150. In this case, the response was demonstrated to be CD8 dependent and was found only in BLV-infected animals (sheep). Knowledge of the location of these T-cell recognition domains will complement data available on B-cell epitopes in gp51 and may be useful in the design of a subunit vaccine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680386      PMCID: PMC240227     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

Review 2.  Protein antigenic structures recognized by T cells: potential applications to vaccine design.

Authors:  J A Berzofsky; K B Cease; J L Cornette; J L Spouge; H Margalit; I J Berkower; M F Good; L H Miller; C DeLisi
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

3.  Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability.

Authors:  C Bruck; N Rensonnet; D Portetelle; Y Cleuter; M Mammerickx; A Burny; R Mamoun; B Guillemain; M J van der Maaten; J Ghysdael
Journal:  Virology       Date:  1984-07-15       Impact factor: 3.616

4.  Topographical analysis by monoclonal antibodies of BLV-gp51 epitopes involved in viral functions.

Authors:  C Bruck; D Portetelle; A Burny; J Zavada
Journal:  Virology       Date:  1982-10-30       Impact factor: 3.616

5.  Immunocompetence of sheep experimentally infected with bovine leukemia virus.

Authors:  G L Cockerell; A L Parodi; D Levy
Journal:  Vet Immunol Immunopathol       Date:  1986-11       Impact factor: 2.046

6.  Induction of lymphosarcoma in sheep by bovine leukemia virus.

Authors:  S J Kenyon; J F Ferrer; R A McFeely; D C Graves
Journal:  J Natl Cancer Inst       Date:  1981-11       Impact factor: 13.506

7.  Isolation of neutrophils and eosinophils from the peripheral blood of cattle and comparison of their functional activities.

Authors:  J A Roth; M L Kaeberle
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

8.  Protection by vaccination against bovine leukemia virus infection in sheep.

Authors:  M Onuma; T Hodatsu; S Yamamoto; M Higashihara; S Masu; T Mikami; H Izawa
Journal:  Am J Vet Res       Date:  1984-06       Impact factor: 1.156

9.  Studies on the relationship between infection with bovine C-type virus, leukemia, and persistent lymphocytosis in cattle.

Authors:  J F Ferrer; D A Abt; D M Bhatt; R R Marshak
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

10.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  11 in total

1.  Dissemination of bovine leukemia virus-infected cells from a newly infected sheep lymph node.

Authors:  B E Fulton; M Portella; K Radke
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Progression to persistent lymphocytosis and tumor development in bovine leukemia virus (BLV)-infected cattle correlates with impaired proliferation of CD4+ T cells in response to gag- and env-encoded BLV proteins.

Authors:  O Orlik; G A Splitter
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  gammadelta(+) T-Lp6phocyte cytotoxicity against envelope-expressing target cells is unique to the alymphocytic state of bovine leukemia virus infection in the natural host.

Authors:  P Lundberg; G A Splitter
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Long-term infection with retroviral structural gene vector provides protection against bovine leukemia virus disease in rabbits.

Authors:  Veronika Altanerova; Dana Holicova; Lucia Kucerova; Cestmir Altaner; Michael D Lairmore; Kathleen Boris-Lawrie
Journal:  Virology       Date:  2004-11-24       Impact factor: 3.616

5.  Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.

Authors:  M H Gatei; H M Naif; S Kumar; D B Boyle; R C Daniel; M F Good; M F Lavin
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

6.  Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade.

Authors:  Ryoyo Ikebuchi; Satoru Konnai; Tatsuya Shirai; Yuji Sunden; Shiro Murata; Misao Onuma; Kazuhiko Ohashi
Journal:  Vet Res       Date:  2011-09-26       Impact factor: 3.683

7.  Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.

Authors:  Lanlan Bai; Hiroyuki Otsuki; Hirotaka Sato; Junko Kohara; Emiko Isogai; Shin-nosuke Takeshima; Yoko Aida
Journal:  Retrovirology       Date:  2015-12-30       Impact factor: 4.602

8.  Mapping of CD4+ T-cell epitopes in bovine leukemia virus from five cattle with differential susceptibilities to bovine leukemia virus disease progression.

Authors:  Lanlan Bai; Shin-Nosuke Takeshima; Masaaki Sato; William C Davis; Satoshi Wada; Junko Kohara; Yoko Aida
Journal:  Virol J       Date:  2019-12-16       Impact factor: 4.099

9.  Agar gel immunodiffusion analysis using baculovirus-expressed recombinant bovine leukemia virus envelope glycoprotein (gp51/gp30(T-)).

Authors:  Seong In Lim; Wooseog Jeong; Dong Seob Tark; Dong Kun Yang; Chang Hee Kweon
Journal:  J Vet Sci       Date:  2009-12       Impact factor: 1.603

Review 10.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.